Product Description

Moluzen contains Molnupiravir 200 mg, an FDA-approved oral antiviral drug for treating mild to moderate COVID-19 in adults at risk of developing severe disease. It works by inhibiting the replication of the SARS-CoV-2 virus, reducing viral load and helping prevent disease progression.

To be effective, treatment should begin within 5 days of symptom onset and under medical supervision.

Benefits

• Reduces risk of hospitalization and severe illness
• Convenient oral capsule form
• Short 5-day treatment course
• Active against multiple COVID-19 variants
• Well tolerated with minimal side effects

Product Details

• Brand: Moluzen
• Generic Name: Molnupiravir
• Strength: 200 mg
• Form: Oral Capsules
• Pack Size: 40 Capsules (5-day course)
• Route: Oral
• Storage: Store in a cool, dry place below 30°C

Dosage & Administration

• Recommended dose: 800 mg (4 capsules) every 12 hours
• Course duration: 5 days
• Start treatment within 5 days after symptoms begin
• Can be taken with or without food
• Complete full course as prescribed

Precautions & Warnings

• Not recommended for pregnant or breastfeeding women
• Use effective contraception during and after treatment (men: 3 months, women: 4 days)
• Not approved for patients under 18 years
• Consult your doctor if you have kidney or liver issues

FAQs

1. What is Moluzen 200 mg used for?

Moluzen is used for treating mild to moderate COVID-19 infection in adults at risk of severe illness.

2. When should I start taking Moluzen?

Begin treatment within 5 days of first COVID-19 symptoms for optimal effectiveness.

3. Can pregnant women take Moluzen?

No. It is not recommended during pregnancy or breastfeeding.

4. Are there any common side effects?

Side effects may include headache, nausea, and diarrhea, usually mild and temporary.

5. Is a prescription required?

Yes, Moluzen is prescription-only and must be taken under medical supervision.